Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03646227 · ClinicalTrials.gov registry record
Multi-Drug Resistant Organism Network
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 6,496
- Enrollment target
NCT03646227 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 6,496 participants.
The verdict
NCT03646227 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 6,496 participants
- Enrollment target
Study Summary
This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO infections. To this end, clinical and epidemiological data will be collected on patients who have MDRO isolated from clinical cultures during hospitalization, as well as descriptions of the outcomes of patients treated with various antimicrobial regimens. Molecular and microbiological characterization will also be performed on MDRO isolates. These data will include a detailed clinical and epidemiological description of patients including identifying potential barriers to enrollment in future trials. In addition, data will be collected on species, strain type, and mechanism of drug resistance of the causative organism. Knowing the molecular characteristics will further inform future trial design as not all diagnostics detect and not all therapeutics are active against the same mechanisms of resistance.
Interventions
- OTHER Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,496 participants |
| Start Date | 2016-06-16 |
| Est. Completion | 2020-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03646227
The ClinicalTrials.gov registry entry for NCT03646227 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,496 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care is the first listed.
NCT03646227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03646227 about?
NCT03646227 is a clinical study titled "Multi-Drug Resistant Organism Network". This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO infections. To this end, clinical and epidemiological data will be collected on patients who have MDRO isolated...
What is the current status of trial NCT03646227?
This trial is currently completed. The enrollment target is 6,496 participants. The study started on 2016-06-16. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03646227?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT03646227?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.